Emetrol Powder Non-Drowsy
Active substance: trisodium citrate
POWDER, FOR SOLUTION · TRISODIUM CITRATE DIHYDRATE 460 mg/1
United StatesActive
Marketing holder: WellSpring Pharmaceutical Corporation
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRISODIUM CITRATE DIHYDRATE · 460 mg/1
Registration
- Registration number
- 65197-203
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 65197-203 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 65197-203 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 65197-203 · Verified 2026-10-09 · open in source